Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
Clinical trial NCT00352378 · COMPLETED
Trial details
- NCT number
- NCT00352378
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2005-10-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.